DAVIS GREGORY D (Head of Research & Technology) reported 2 transactions at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2026ACC: 0002041855-26-000004
Officer· Head of Research & Technology
Since Feb 2026
-5.95K
Net shares
Net seller
$2.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
5.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−832.00
Price / share
$0.47
Trade value
$393.12
% of position
0.4%
2/24/2026
191.06K→190.23K
Common Stock
Direct
Shares
−5.12K
Price / share
$0.47
Trade value
$2.41K
% of position
2.7%
2/25/2026
190.23K→185.11K
Total
Net shares
−5.95K
Net value
-$2.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −832.00 | $0.47 | $393.12 | 0.4% | 191.06K | 190.23K |
| Common Stock Direct | 2/25/2026 | F · Tax Withholding | −5.12K | $0.47 | $2.41K | 2.7% | 190.23K | 185.11K |
| Total | −5.95K | -$2.80K | ||||||
Derivative Transactions0
No derivative transactions reported